Tag Archives: Patent Law

“Handbook of Quality Procedures Before the EPO”

Posted on March 26, 2012 by Warren Woessner

The ECP, epi and Business Europe have collaborated to produce a downloadable, fifty page guide to practice before the EPO. While not binding on Examiners, it was issued under the authority of the EPO and is a sort of mini-MPEP, … Continue reading →

Posted in EP and UK Practice | Tagged biotechnology law, epi, EPO, European patent, intellectual property, ip, Patent Law, patents, Warren Woessner | Leave a comment

PTO To Biotech Examiners – We’ll Get Back To You!

Posted on March 26, 2012 by Warren Woessner

On March 21, 2012, Andrew H Hirschfield, Associate Commissioner for Patent Examination Policy, sent a short memo to the Patent Examining Corps to inform them about the decision in Prometheus v. Mayo. The “preliminary guidance” that was provided included a … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Andrew H Hirschfield, Bilski, Patent Law, Prometheus v. Mayo, USPTO, Warren Woessner | Leave a comment

Unnatural Acts – Patenting Diagnostic Tests Post-Prometheus

Posted on March 23, 2012 by Warren Woessner

The US Supreme Court case of Mayo v. Prometheus has generated a lot of interest precisely because it clouds the future of patent claims to diagnostic methodologies in general and to ‘personalized medicine’ in specific. The decision is likely to … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Patent Law, Prometheus v. Mayo, Supreme Court, Warren Woessner | 1 Comment

Indian Patent Office Grants Compulsory License To Bayer Drug

Posted on March 21, 2012 by Warren Woessner

Finding that Bayer had failed the requirement to “work” the invention in India, e.g., manufacture and sell at a reasonable price, the Indian Patent Office granted Natco Pharma, an Indian company, a “compulsory license” to make, use and sell a … Continue reading →